Recipharm’s Acquisition of Additional Stake in Nichepharm Lifesciences

Khaitan & Co. advised Nichepharm Lifesciences Private Limited and the promoters on the transaction.

Recipharm AB executed the acquisition of an additional stake in Nichepharm from Nichepharm Lifesciences Private Limited (Nichepharm) and the Sobti family.

Recipharm AB publ specializes in contract development and manufacture of pharmaceuticals. The Company manufactures products in forms that include solid dose, granulates and powders, sterile liquids and lyophilisates, semi solids, hormones, oral liquids, sprays, and dry powder inhalers.

The Khaitan & Co. team was led by Partner Kalpana Unadkat (Picture), Purti Minawala (Principal Associate) and Sweta Rao (Senior Associate).

Involved fees earner: Purti Minawala – Khaitan & Co.; Sweta Rao – Khaitan & Co.; Kalpana Unadkat – Khaitan & Co.;

Law Firms: Khaitan & Co.;

Clients: Nichepharm Lifesciences;

Author: Sonia Carcano